| HOME >> BIOLOGY >> TECHNOLOGY |
Table 117: United States size of population (million), 2007–11 196
Table 118: United States gdp (constant 2000 prices, $ billion), 2007–11 196
Table 119: United States gdp (current prices, $ billion), 2007–11 196
Table 120: United States inflation, 2007–11 197
Table 121: United States consumer price index (absolute), 2007–11 197
Table 122: United States exchange rate, 2007–11 197
Table 123: Amgen, Inc.: key facts 198
Table 124: Amgen, Inc.: key financials ($) 199
Table 125: Amgen, Inc.: key financial ratios 199
Table 126: Covance Inc.: key facts 201
Table 127: Covance Inc.: key financials ($) 202
Table 128: Covance Inc.: key financial ratios 202
Table 129: Merck & Co., Inc.: key facts 204
Table 130: Merck & Co., Inc.: key financials ($) 205
Table 131: Merck & Co., Inc.: key financial ratios 205
Table 132: F. Hoffmann-La Roche Ltd: key facts 207
Table 133: F. Hoffmann-La Roche Ltd: key financials ($) 208
Table 134: F. Hoffmann-La Roche Ltd: key financials (CHF) 208
Table 135: F. Hoffmann-La Roche Ltd: key financial ratios 208
Table 136: Astellas Pharma Inc.: key facts 210
Table 137: Astellas Pharma Inc.: key financials ($) 211
Table 138: Astellas Pharma Inc.: key financials (¥) 211
Table 139: Astellas Pharma Inc.: key financial ratios 211
Table 140: Kyowa Hakko Kirin Co., Ltd.: key facts 213
Table 141: Kyowa Hakko Kirin Co., Ltd.: key financials ($) 214
Table 142: Kyowa Hakko Kirin Co., Ltd.: key financials (¥) 214
Table 143: Kyowa Hakko Kirin Co., Ltd.: key financial ratios 214
Table 144: Mitsubishi Tanabe Pharma Corporation: key facts 216
Table 145: Mitsubishi Tanabe Pharma Corporation: key financials ($) 216
Table 146: Mitsu
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |